<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0223829.ref009">
 <label>9</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Donoghoe</surname>
   <given-names>MC</given-names>
  </name>, 
  <name>
   <surname>Bollerup</surname>
   <given-names>AR</given-names>
  </name>, 
  <name>
   <surname>Lazarus</surname>
   <given-names>JV</given-names>
  </name>, 
  <name>
   <surname>Nielsen</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Matic</surname>
   <given-names>S</given-names>
  </name>. 
  <article-title>Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002–2004</article-title>. 
  <source>Int J Drug Policy</source>. 
  <year>2007</year>;
  <volume>18</volume>: 
  <fpage>271</fpage>–
  <lpage>80</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.drugpo.2007.02.010</pub-id>
  <?supplied-pmid 17689375?>
  <pub-id pub-id-type="pmid">17689375</pub-id>
 </mixed-citation>
</ref>
